Cancer advocacy is not often top of mind, even for patients and families facing active diagnoses and treatments for cancer. However, with the added impact of COVID-19 on our health and well being, advocacy and service in the cancer space is becoming more important than ever. That is one of the messages that came from a webinar I participated in this morning on “Cancer Care Patient Advocacy Perspectives” as part of a series of discussions being presented over the course of several months by the Association for Value Based Cancer Care. Organizations providing advocacy and service to those with cancer… Read More »Cancer Advocacy: A Precious Resource In A Time Of Immense Needs
16 million cancer survivors in the United States, growing every year. Success stories we never would have imagined even a decade ago. And yet, when it comes to genuinely understanding the impacts of cancer treatments and what happens over the long term to young and older survivors alike, we are woefully uniformed and under-prepared—and as a nation don’t have a unified plan to address the issue. That’s my take away nugget from a two day workshop just completed on “Addressing the Adverse Consequences of Cancer Treatment,” convened by the National Cancer Policy Forum, which is part of the National Academies… Read More »It’s Time To Address The Needs Of Cancer Survivors
Hydroxychloroquine has become a part of the COVID story that will not go away. And with another research study reported today in JAMA showing no benefit of the drug in hospitalized patients with COVID-19, the journal asks the fundamental question: Why do we continue to believe this drug has benefit in treating this pandemic illness, and why won’t science prevail? To which we respond: Why are we surprised???? The study, performed by a clinical trial collaborative under the guidance of the National Heart and Lung Institute of the National Institutes of Health included 479 patients in 34 hospitals around the… Read More »Hydroxychlorqine for COVID-19: Time To Move On?